Health disparities and clinical trial recruitment: Is there a duty to tweet?
Health disparities and clinical trial recruitment: Is there a duty to tweet?
复制标题
DOI：
10.1371/journal.pbio.2002040
复制
发表时间：
2017-03
期刊：
影响因子：
9.8
通讯作者：
Friesen P
中科院分区：
文献类型：
--
作者：
Caplan A;Friesen P
众所周知，临床试验参与者的同质性常常威胁到获得普遍知识的目标，但研究人员经常引用招募问题，包括参与者缺乏兴趣、资源短缺或难以接触特定人群，来解释抽样中缺乏多样性的原因。有人建议，社交媒体可能会提供一个机会，通过负担得起的、有针对性的招聘广告或信息来克服这些障碍。然而，招聘人员被警告要谨慎使用这些手段，因为与隐私和透明度相关的风险可能会呈现出新的面貌。
While it is well known that the homogeneity of clinical trial participants often threatens the goal of attaining generalizable knowledge, researchers often cite issues with recruitment, including a lack of interest from participants, shortages of resources, or difficulty accessing particular populations, to explain the lack of diversity within sampling. It is proposed that social media might provide an opportunity to overcome these obstacles through affordable, targeted recruitment advertisements or messages. Recruiters are warned, however, to be cautious using these means, since risks related to privacy and transparency can take on a new hue.